Foveoschisis associated with gyrate atrophy in ornithine aminotransferase deficiency: A case report

Photodiagnosis Photodyn Ther. 2023 Jun:42:103618. doi: 10.1016/j.pdpdt.2023.103618. Epub 2023 May 19.

Abstract

Ornithine aminotransferase (OAT) deficiency is an autosomal recessive disease characterized by elevated serum ornithine levels caused by mutations in genes encoding for ornithine aminotransferase, a vitamin B6-dependent mitochondrial matrix enzyme. Gyrate atrophy (GA) is characteristic findings in OAT that characterized by sharply demarcated circular, pigmentary, brain-like areas of chorioretinal atrophy in the peripheral retina. This case report presents rare assosiation between OAT and GA and describes the characteristic imaging findings of this unique, not fully understood clinical entity. The coexistence of GA and foveoschisis is extremely rare in OAT deficiency. We report a case of foveoschisis in a patient with OAT, and we will discuss the possible mechanisms that lead to it. A 24-year-old male patient presented with complaints of decreased vision and nictalopia for 1 year. The patient, who was diagnosed with oat 6 years ago, had typical gyrate atrophy in his Fundus floresein angiography and foveoschisis in his Optical coherence tomography. He was diagnosed with gyrate atrophy and foveoschisis. GA caused by OAT deficiency may present with macular involvement in the form of foveoschisis causing central visual impairment. Ophthalmologists should not ignore detailed fundus examination in children and young patients with visual impairment and should be aware of possible systemic diseases.

Keywords: Foveoschisis; Gyrate atrophy; OCT; Ornithine aminotransferase deficiency; Vision loss.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Atrophy
  • Child
  • Gyrate Atrophy* / complications
  • Gyrate Atrophy* / diagnosis
  • Gyrate Atrophy* / drug therapy
  • Humans
  • Male
  • Ornithine-Oxo-Acid Transaminase / genetics
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Retina
  • Young Adult

Substances

  • Ornithine-Oxo-Acid Transaminase
  • Photosensitizing Agents